Subscribe To
Reviva Pharmaceuticals Announces Intent to File an IND for Brilaroxazine in Psoriasis After Promising Preclinical Data
Brilaroxazine topical liposomal-gel formulation (brilaroxazine lipogel) demonstrated proof-of-concept efficacy in the imiquimod-induced psoriatic mouse model IND submission for brilaroxazine lipogel in psoriasis expected in 2024 Reviva has filed composition of matter patent for brilaroxazine-lipogel and a separate patent for use in the treatment of psoriasis Preclinical efficacy data presented at the ISID 2023 meeting CUPERTINO, […] The post Reviva Pharmaceuticals Announces Intent to File an IND...
Read More
Content Topics
Reviva
Pharmaceuticals
Announces
Intent
File
Brilaroxazine
Psoriasis
Promising
Preclinical
Forex
Posted: May 11 2023, 10:30
Author Name: forextv
Views: 102213